Monday, 22 June 2015

Technology Advancements To Make PAP Tests Safe And Hassle-free

Early this month, the ‘Guided Therapeutics Inc.’ brought into light that its distributor in Bangladesh has backed nearly four contracts for LuViva®. The company adds that the demand has tremendously increased when compared to other nations that have already used the service of LuViva like a triage system to reduce costs and recognize false positives often caused by Prostaticacid phosphatase testing technologies in screening procedures. Furthermore, the Laboratory Corp. of America Holdings declared in June 2015 the availability of LabCorp AccuDraw® that would facilitate the collection and handling of the specimen to its buyers via its company site, i.e. crucial for PAP tests. 

Weill Cornell that has a very strong presence in countries including Turkey, Qatar, Austria, Tanzania, Brazil and Haiti has emerged as the birthplace of an array of several medical development – that consists of the progress in the prostatic acid phosphatase testing technologies for cervical cancer. To top it all, The Memorial Hospital, at Craig has bought a cutting –edge mammography device which can offers a clear, more accurate images – backed by 3-D  technology to be included soon. Apart from this the hospital has made a great progress in screening technology for women in PAP tests for cervical cancer. Recently Research Beam has added a report titled “2015 Prostatic Acid PhosphataseTesting Technologies and Emerging Markets.” The report takes a closer look at the PAP testing industry in countries such as Spain, Japan, France, United States, Germany and Italy among many other countries. 

Besides, advancements in the testing technologies the partnership agreement between The Algoma Nurse Practitioner-Led Clinic and The Neighbourhood Resource Centre, aims to bring to many an open and hassle-free access to safe PAP or screening test. Health officials across the globe emphasise on PAP test for women around 22 years or above, every year. Eyeing the technology developments and partnerships taking place in the prostatic acid phosphatase testing technology market, its future looks promising. 

No comments:

Post a Comment